These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 10447032)

  • 21. [Immunity against diphtheria and tetanus in the adult Polish population].
    Walory J; Grzesiowski P; Hryniewicz W
    Pol Merkur Lekarski; 2000 Oct; 9(52):687-92. PubMed ID: 11144058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.
    McIntyre PB; Turnbull FM; Egan AM; Burgess MA; Wolter JM; Schuerman LM
    Vaccine; 2004 Dec; 23(3):380-5. PubMed ID: 15530684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
    Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
    APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxoid vaccine for pertussis.
    Preston NW; Matthews RC
    Lancet; 1997 Jan; 349(9045):137; author reply 137-8. PubMed ID: 8996452
    [No Abstract]   [Full Text] [Related]  

  • 25. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
    Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Data on the response to and efficacy of pertussis and pertussis-diphtheria vaccine].
    KOZLOVA NA
    Vopr Okhr Materin Det; 1961 Feb; 6():34-8. PubMed ID: 13753785
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions.
    Khetsuriani N; Music S; Deforest A; Sutter RW
    J Infect Dis; 2000 Feb; 181 Suppl 1():S208-12. PubMed ID: 10657216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned.
    Schneerson R; Robbins JB; Taranger J; Lagergård T; Trollfors B
    Lancet; 1996 Nov; 348(9037):1289-92. PubMed ID: 8909384
    [No Abstract]   [Full Text] [Related]  

  • 32. Diphtheria antitoxin levels among children primed with a diphtheria and tetanus toxoids and acellular pertussis vaccine lot with a subpotent diphtheria toxoid component.
    Jackson LA; Falls S; Yu O; George J; Pietrobon PJ; Rubanowice D; Froeschle J
    J Infect Dis; 2001 Jun; 183(11):1698-700. PubMed ID: 11343223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the problem of reactogenic properties of pertussis-diphtheria vaccine. I. Sensitizing properties of pertussis-diphtheria vaccine].
    KOLCHURINA AA
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Oct; 30():32-3. PubMed ID: 14410678
    [No Abstract]   [Full Text] [Related]  

  • 34. Serological immunity to diphtheria and tetanus in healthy adults in Delhi, India.
    Saxena S; Jais M; Dutta R; Dutta AK
    Trop Doct; 2009 Jul; 39(3):160-3. PubMed ID: 19535754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative indices of immunological changes in children following vaccination against whooping cough and after inoculation with whooping cough-diphtheria vaccine and diphtherial anatoxin].
    KUZNETSOVA LS
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Sep; 30():33-8. PubMed ID: 14413037
    [No Abstract]   [Full Text] [Related]  

  • 36. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 37. An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.
    Pichichero ME; DeTora LM; Johnson DR
    Expert Rev Vaccines; 2006 Apr; 5(2):175-87. PubMed ID: 16608418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
    Chan SH; Tan PT; Han HH; Bock HL
    Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibody response in children to individual components of poliomyelitis vaccine combined with pertussis vaccine and diphtheria and tetanus anatoxins].
    PRASILOVA F; KRYL R; ZACEK K; VYSOKA B; JANDA J
    Cesk Epidemiol Mikrobiol Imunol; 1960 Jul; 9():413-20. PubMed ID: 13737738
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diphtheria antitoxin level 2 years after booster vaccination].
    Nicolay U; Girgsdies OE; Banzhoff A; Hundt E; Kondler-Budde R; Lober R; Hainz R; Jilg W
    Wien Med Wochenschr; 2000; 150(22):435-9. PubMed ID: 11191952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.